Hypoglycemic Coma in a Hemodialysis Patient Receiving Blood Glucose-Lowering Therapy With the Single Agent Teneligliptin
Blood glucose management in patients undergoing dialysis is clinically challenging. In this population, most conventional oral hypoglycemic agents are contraindicated, especially from the perspective of pharmacokinetics. Dipeptidyl peptidase-4 inhibitors exert unique pharmacologic actions via glucos...
Main Authors: | Takumi Minezumi, Shin-ichi Takeda, Yusuke Igarashi, Kentaro Sato, Yoshiaki Murakami, Daisuke Nagata |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-03-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.1177/1179547618763358 |
Similar Items
-
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
by: Okuda Y, et al.
Published: (2016-04-01) -
MAGNETIC RESONANCE IMAGING IN HYPOGLYCEMIC COMA
by: C. IONETE
Published: (2009-06-01) -
Silent myocardial infarction during hypoglycemic coma
by: Varun Vijay Mahajan, et al.
Published: (2012-01-01) -
Efficacy and safety of teneligliptin
by: Awadhesh Kumar Singh
Published: (2017-01-01) -
The effects of hypoglycemic and alcoholic coma on the blood-brain barrier permeability
by: Hatice Yorulmaz, et al.
Published: (2011-05-01)